A novel short splice variant of the tumour suppressor LKB1 is required for spermiogenesis.

Division of Molecular Physiology, School of Life Sciences, University of Dundee, Dundee, Scotland, UK.
Biochemical Journal (Impact Factor: 4.78). 10/2008; 416(1):1-14. DOI: 10.1042/BJ20081447
Source: PubMed

ABSTRACT LKB1 was discovered as a tumour suppressor mutated in Peutz-Jeghers syndrome, and is a gene involved in cell polarity as well as an upstream protein kinase for members of the AMP-activated protein kinase family. We report that mammals express two splice variants caused by alternate usage of 3'-exons. LKB1(L) is the previously described form, while LKB1(S) is a novel form in which the last 63 residues are replaced by a unique 39-residue sequence lacking known phosphorylation (Ser(431)) and farnesylation (Cys(433)) sites. Both isoforms are widely expressed in rodent and human tissues, although LKB1(S) is particularly abundant in haploid spermatids in the testis. Male mice in which expression of Lkb1(S) is knocked out are sterile, with the number of mature spermatozoa in the epididymis being dramatically reduced, and those spermatozoa that are produced have heads with an abnormal morphology and are non-motile. These results identify a previously undetected variant of LKB1, and suggest that it has a crucial role in spermiogenesis and male fertility.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The AMP-activated protein kinase (AMPK) is a sensor of cellular energy and nutrient status, expressed almost universally in eukaryotes as heterotrimeric complexes comprising catalytic (α) and regulatory (β and γ) subunits. Along with the mechanistic target of rapamycin complex-1 (mTORC1), AMPK may have been one of the earliest signaling pathways to have arisen during eukaryotic evolution. Recent crystal structures have provided insights into the mechanisms by which AMPK is regulated by phosphorylation and allosteric activators. Another recent development has been the realization that activation of AMPK by the upstream kinase LKB1 may primarily occur not in the cytoplasm, but at the surface of the lysosome, where AMPK and mTORC1 are regulated in a reciprocal manner by the availability of nutrients. It is also becoming clear that there is a substantial amount of crosstalk between the AMPK pathway and other signaling pathways that promote cell growth and proliferation, and this will be discussed. Copyright © 2014 Elsevier Inc. All rights reserved.
    Cell metabolism. 12/2014; 20(6):939-952.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Liver kinase B1 (LKB1), known as a serine/threonine kinase, has been identified as a critical cancer suppressor in many cancer cells. It is a master upstream kinase of 13 AMP-activated protein kinase (AMPK)-related protein kinases, and possesses versatile biological functions. LKB1 gene is mutated in many cancers, and its protein can form different protein complexes with different cellular localizations in various cell types. The expression of LKB1 can be regulated through epigenetic modification, transcriptional regulation and post-translational modification. LKB1 dowcnstream pathways mainly include AMPK, microtubule affinity regulating kinase (MARK), salt-inducible kinase (SIK), sucrose non-fermenting protein-related kinase (SNRK) and brain selective kinase (BRSK) signalings, etc. This review, therefore, mainly discusses recent studies about the expression, regulation, downstream signaling and cancer suppressive function of LKB1, which can be helpful for better understanding of this molecular and its significance in cancers.
    International Journal of Molecular Sciences 09/2014; 15(9):16698-16718. · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Avian gametes present specific features related to their internal long-term mode of fertilization. Among other central actors of energetic metabolism control, 5'-AMP-activated protein kinase (AMPK) has been suspected to influence sperm functions and thus to play a key role in fertilization success. In the present work, we studied AMPK localization and function in chicken sperm incubated in vitro. Effects of the pharmacological AMPK activators (AICAR, Metformin) and the AMPK inhibitor Compound C were assessed by evaluating AMPKalpha (Thr(172)) phosphorylation (Western blotting), semen quality (viability, motility, ability to perform acrosome reaction), and energetic metabolism indicators (lactate, ATP). Localization of AMPK in the subcellular sperm compartments was evaluated by immunocytochemistry. Total AMPK was found in all compartments except the nucleus but the phosphorylated form, phospho-Thr(172)-AMPK, was essentially localized in the flagellum and the acrosome. The AMPK activators significantly improved AMPK phosphorylation, sperm motility (increase by 40% of motile, 90% of progressive and 60% of rapid sperm), acrosome reaction and lactate production (increase by 40%) and viability. The AMPK inhibitor significantly reduced AMPK phosphorylation and percentages of motile (decrease by 25%), progressive (decrease by 35%), and rapid sperm (decrease by 30%), acrosome reaction, lactate production, and ATP release. The two activators differed in their effect on ATP concentration: AICAR stimulated ATP formation whereas Metformin did not. Our results indicate that AMPK plays a key role in the regulation of chicken sperm functions and metabolism. This action differs from the one suggested in mammals, mainly by its crucial involvement in the acrosome reaction process.
    Biology of Reproduction 10/2014; · 3.45 Impact Factor

Mhairi Towler